The relationship between ovarian progesterone and proteolytic enzyme activity during ovulation in the gonadotropin-treated immature rat.
To clarify the mechanisms by which progesterone acts as a mediator in the ovulatory process, ovulation rate and proteolytic enzyme activities were investigated in immature 22-day-old rats treated with PMSG/hCG, RU486 (10 mg/kg), synthetic antiprogesterone, and RU486 (10 mg/kg) + progesterone (10 mg/kg). The number of ova was significantly decreased when RU486 (10 mg/kg) was given from 2 h before to 4 h after the hCG injection. In addition, its inhibitory action on ovulation was reversed by exogenous progesterone (10 mg/kg) at 2 or 4 h after the hCG injection. Serum progesterone and estradiol concentrations in the rats treated with RU486 did not show any significant differences compared to controls. The proteolytic enzyme activities were measured by using the synthetic substrates alpha-N-benzoyl-DL-Arg-beta naphthylamide (BANA) and dinitrophenyl peptide (DNP). Activities were significantly increased after hCG injection in the control group during 8-9 h for BANA hydrolase and 7-10 h for DNP peptidase. The preovulatory increase of these activities was totally suppressed by RU486 with hCG. After administration of progesterone (10 mg/kg) following hCG and RU486 injection, the elevation of proteolytic, enzyme activities in the preovulatory phase was effectively reversed, and levels became similar to those in the control group. These results suggest that progesterone plays an indispensable role in the first 4 h of the ovulatory process by regulating proteolytic enzyme activities.
Iwamasa
J
J
Department of Obstetrics and Gynecology, Kumamoto University Medical School, Japan.
Shibata
S
S
Tanaka
N
N
Matsuura
K
K
Okamura
H
H
D000818:Animals; D056655:Cathepsin H; D002403:Cathepsins / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003546:Cysteine Endopeptidases; D004140:Dinitrophenols; D004958:Estradiol / Q000097:blood; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology; D015735:Mifepristone / Q000494:pharmacology; D009842:Oligopeptides; D010053:Ovary / Q000187:drug effects / Q000378:metabolism; D010060:Ovulation / Q000187:drug effects / Q000502:physiology*; D010447:Peptide Hydrolases / Q000378:metabolism*; D011374:Progesterone / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D006063:Chorionic Gonadotropin; D004140:Dinitrophenols; D006064:Gonadotropins, Equine; D009842:Oligopeptides; D015735:Mifepristone; D011374:Progesterone; D004958:Estradiol; C024118:DNP-peptide; D002403:Cathepsins; D010447:Peptide Hydrolases; D003546:Cysteine Endopeptidases; D056655:Cathepsin H; C534128:Ctsh protein, rat